Login
Home
Charts
Search
Watchlist
Products

ARCL Organics Ltd

ARCL·BSE
264.95+3.76%Wed, 23 Sept '26

ARCL Organics Ltd

ARCL
BSE
264.95
+3.76%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
212Cr
Close
Close Price
264.95
Industry
Industry
Chemicals - Others
PE
Price To Earnings
20.54
PS
Price To Sales
0.78
Revenue
Revenue
272Cr
Rev Gr TTM
Revenue Growth TTM
5.40%
PAT Gr TTM
PAT Growth TTM
-23.89%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
434858605662726786536567
Growth YoY
Revenue Growth YoY%
5.552.424.044.130.528.225.512.452.7-13.7-9.6-0.6
Expenses
ExpensesCr
404152545158636175545851
Operating Profit
Operating ProfitCr
47565496110716
OPM
OPM%
8.714.89.29.69.36.212.49.613.3-0.610.823.4
Other Income
Other IncomeCr
111011011111
Interest Expense
Interest ExpenseCr
110111111122
Depreciation
DepreciationCr
111111111222
PBT
PBTCr
2554427510-3413
Tax
TaxCr
120121113624
PAT
PATCr
145322647-939
Growth YoY
PAT Growth YoY%
-55.01,900.0189.741.374.4-52.911.144.0231.2-592.2-50.2128.6
NPM
NPM%
2.97.98.84.63.92.97.85.98.4-16.54.313.6
EPS
EPS
1.64.86.33.52.72.27.05.09.0-11.03.511.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
434858605662726786536567
Growth YoY
Revenue Growth YoY%
5.552.424.044.130.528.225.512.452.7-13.7-9.6-0.6
Expenses
ExpensesCr
404152545158636175545851
Operating Profit
Operating ProfitCr
47565496110716
OPM
OPM%
8.714.89.29.69.36.212.49.613.3-0.610.823.4
Other Income
Other IncomeCr
111011011111
Interest Expense
Interest ExpenseCr
110111111122
Depreciation
DepreciationCr
111111111222
PBT
PBTCr
2554427510-3413
Tax
TaxCr
120121113624
PAT
PATCr
145322647-939
Growth YoY
PAT Growth YoY%
-55.01,900.0189.741.374.4-52.911.144.0231.2-592.2-50.2128.6
NPM
NPM%
2.97.98.84.63.92.97.85.98.4-16.54.313.6
EPS
EPS
1.64.86.33.52.72.27.05.09.0-11.03.511.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
717187141165191251272272
Growth
Revenue Growth%
0.022.463.016.815.631.48.75.4
Expenses
ExpensesCr
676474126147171227248238
Operating Profit
Operating ProfitCr
4712151819242534
OPM
OPM%
5.99.414.110.810.810.19.59.112.4
Other Income
Other IncomeCr
112233233
Interest Expense
Interest ExpenseCr
232123456
Depreciation
DepreciationCr
111134567
PBT
PBTCr
1311151715171725
Tax
TaxCr
01345341215
PAT
PATCr
13811121112510
Growth
PAT Growth%
127.5218.331.110.9-3.29.1-57.9-23.9
NPM
NPM%
1.63.69.37.57.15.94.91.93.8
EPS
EPS
1.43.210.013.214.614.115.46.512.9
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
717187141165191251272272
Growth
Revenue Growth%
0.022.463.016.815.631.48.75.4
Expenses
ExpensesCr
676474126147171227248238
Operating Profit
Operating ProfitCr
4712151819242534
OPM
OPM%
5.99.414.110.810.810.19.59.112.4
Other Income
Other IncomeCr
112233233
Interest Expense
Interest ExpenseCr
232123456
Depreciation
DepreciationCr
111134567
PBT
PBTCr
1311151715171725
Tax
TaxCr
01345341215
PAT
PATCr
13811121112510
Growth
PAT Growth%
127.5218.331.110.9-3.29.1-57.9-23.9
NPM
NPM%
1.63.69.37.57.15.94.91.93.8
EPS
EPS
1.43.210.013.214.614.115.46.512.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
88888888
Reserves
ReservesCr
1416243546586974
Current Liabilities
Current LiabilitiesCr
2619274650686898
Non Current Liabilities
Non Current LiabilitiesCr
91191016232340
Total Liabilities
Total LiabilitiesCr
57556898120157169220
Current Assets
Current AssetsCr
333347717393101123
Non Current Assets
Non Current AssetsCr
2422212747646898
Total Assets
Total AssetsCr
57556898120157169220
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
88888888
Reserves
ReservesCr
1416243546586974
Current Liabilities
Current LiabilitiesCr
2619274650686898
Non Current Liabilities
Non Current LiabilitiesCr
91191016232340
Total Liabilities
Total LiabilitiesCr
57556898120157169220
Current Assets
Current AssetsCr
333347717393101123
Non Current Assets
Non Current AssetsCr
2422212747646898
Total Assets
Total AssetsCr
57556898120157169220

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-266225135-4
Investing Cash Flow
Investing Cash FlowCr
-40-1-7-22-21-9-34
Financing Cash Flow
Financing Cash FlowCr
7-5-4547232
Net Cash Flow
Net Cash FlowCr
001-17-1-2-5
Free Cash Flow
Free Cash FlowCr
-755-63-8-5-39
CFO To PAT
CFO To PAT%
-214.7234.978.717.5215.1113.443.4-72.8
CFO To EBITDA
CFO To EBITDA%
-57.289.051.812.1140.566.322.4-15.3
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-266225135-4
Investing Cash Flow
Investing Cash FlowCr
-40-1-7-22-21-9-34
Financing Cash Flow
Financing Cash FlowCr
7-5-4547232
Net Cash Flow
Net Cash FlowCr
001-17-1-2-5
Free Cash Flow
Free Cash FlowCr
-755-63-8-5-39
CFO To PAT
CFO To PAT%
-214.7234.978.717.5215.1113.443.4-72.8
CFO To EBITDA
CFO To EBITDA%
-57.289.051.812.1140.566.322.4-15.3

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
35183121212
Price To Earnings
Price To Earnings
3.114.823.220.5
Price To Sales
Price To Sales
0.20.70.40.8
Price To Book
Price To Book
0.52.41.52.6
EV To EBITDA
EV To EBITDA
2.58.46.87.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
23.631.833.026.227.026.125.527.327.3
OPM
OPM%
5.99.414.110.810.810.19.59.112.4
NPM
NPM%
1.63.69.37.57.15.94.91.93.8
ROCE
ROCE%
8.215.431.628.325.018.718.814.414.4
ROE
ROE%
5.010.425.024.821.517.315.96.36.3
ROA
ROA%
2.04.611.810.89.77.27.32.42.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
35183121212
Price To Earnings
Price To Earnings
3.114.823.220.5
Price To Sales
Price To Sales
0.20.70.40.8
Price To Book
Price To Book
0.52.41.52.6
EV To EBITDA
EV To EBITDA
2.58.46.87.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
23.631.833.026.227.026.125.527.327.3
OPM
OPM%
5.99.414.110.810.810.19.59.112.4
NPM
NPM%
1.63.69.37.57.15.94.91.93.8
ROCE
ROCE%
8.215.431.628.325.018.718.814.414.4
ROE
ROE%
5.010.425.024.821.517.315.96.36.3
ROA
ROA%
2.04.611.810.89.77.27.32.42.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
ARCL Organics is a specialty-chemicals company built on a single, integrated manufacturing complex in Kolkata - but its real story is a 40-year turnaround led by a former chemical trader who bought a loss-making unit in 1983 and methodically expanded it from a plywood-adhesive supplier into a diversified, export-facing producer of resins, hardeners and tailor-made formulations. The recurring approach is visible in every chapter: master one core chemistry - formaldehyde - then layer on adjacent products, in-house R&D and acquired capacity, always funding the next step from the last. # Business segments A single engine with many grades - a formaldehyde-based specialty-chemicals platform that sells resins, additives and hardeners to industries from plywood to automotive, built through organic expansion and bolt-on acquisitions. ## 1. Formaldehyde-based specialty chemicals: the platform that turns one molecule into many industries **ARCL makes formaldehyde and then upgrades it into a family of resins and hardeners - so the same factory serves plywood makers, construction firms, dairies and car-parts suppliers, all from one integrated complex.** - **One molecule, many products** - the company starts with formaldehyde and builds out into phenolics, amino resins, melamine resins, epoxy resin and specialised one-shot resins, plus the additives and hardeners that go with them. That means it captures value at every step rather than selling a single intermediate. - **Tailor-made, not just off-the-shelf** - ARCL formulates solutions to a client's exact specification, which turns a commodity input into a stickier, higher-value product. This is how a mid-sized Indian plant competes with global chemical houses. - **In-house R&D with government backing** - the company's laboratory is DSIR-certified by the Government of India, so product development is not outsourced and new grades can be created on-site. R&D spending was about ₹1.04 crore in FY24, roughly half a percent of turnover. - **Bought, not just built** - three acquisitions in Gujarat between 2022 and 2026 - RCHEM Industries, Vishvam Formalin and Angel Resins - added land, plant and machinery making powder resins for a combined consideration of roughly ₹29 crore plus taxes. These bolt-ons strengthen the manufacturing footprint without starting from scratch. - **Export reach without a separate division** - overseas sales contributed about a third of manufactured-goods revenue in FY25, yet the company treats the whole of India as one geographical segment because the same complex serves both domestic and export customers. That keeps the operating structure simple even as the customer base spreads. # Group structure and partners **ARCL sits atop seven wholly owned Indian subsidiaries that do not make chemicals - they finance real estate, trade and other activities - so the listed entity is a pure-play specialty-chemicals manufacturer with a separate group around it.** - **Seven wholly owned subsidiaries, none in chemicals** - Yocnex Chemicals, Suksess Chemicals, Nocnex Chemicals, Ocilim Advisory Services, Wide Range Merchants, Allied Maritime & Infra Engineering and ARCL Petrochemicals are all fully owned and engaged in real-estate development financing, trading and other activities, not in the parent's manufacturing business. - **No associates, no joint ventures** - as of March 2025 the company had no other equity-accounted entities, so the structure is deliberately simple: one operating company and a ring-fenced set of non-operating subsidiaries. - **One acquisition still in transit** - RCHEM Industries, bought through NCLT proceedings in March 2022 for ₹3.01 crore, had not yet had its shares transferred into ARCL's name as of March 2026, so it sits on the balance sheet as an asset rather than a consolidated subsidiary.

Documents — ARCL Organics Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/6muqeg1fstf5nnessd3ot0lz.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/x8hht4ukdg84xjtlyckfmlr4.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/gi1cs7cho78oyi7m56fb5wbb.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/kcaixfxmcqpt1ui4rivm7295.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/dmx5ax3djhtkbs2g9l9467s2.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/hb1x2686sbktd3xzoevciry4.pdf
  • Q3 FY2024 Quarterly Result (Dec 2023, PDF): https://www.stockscans.in/document/mbji5zncxkqkg27kun37ruv0.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/stjgw639d2neqepkkczixx9v.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/ry7juoghv0gnt7s21z9lm2uy.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/553ztbkaxyeiw60y0mdex45r.pdf